GlaxoSmithKline (GB:GSK)
LSE:GSK
UK Market
Advertisement

GlaxoSmithKline (GSK) Technical Analysis

Compare
1,102 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is 54.48, suggesting GlaxoSmithKline is a Sell.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 1737.08, while GlaxoSmithKline’s (GSK) share price is 1,784p, making it a Buy.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 1643.30, while GlaxoSmithKline’s (GSK) share price is 1,784p, making it a Buy.

GlaxoSmithKline (GSK) Pivot Points

Nov 18, 2025, 07:48 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1,737.67
1,757.33
1,770.67
1,790.33
1,803.67
1,823.33
1,836.67
Fibonacci
1,757.33
1,769.94
1,777.73
1,790.33
1,802.94
1,810.73
1,823.33
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Nov 18, 2025, 07:48 AM
Period
Simple
Exponential
MA5
1,802.00Sell
1,793.27Buy
MA10
1,782.84Buy
1,777.02Buy
MA20
1,730.05Buy
1,737.08Buy
MA50
1,619.26Buy
1,643.30Buy
MA100
1,508.66Buy
1,557.55Buy
MA200
1,454.66Buy
1,475.89Buy
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 1777.02, while GlaxoSmithKline’s (GSK) share price is 1,784p, making it a Buy.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 1557.55, while GlaxoSmithKline’s (GSK) share price is 1,784p, making it a Buy.
GlaxoSmithKline’s (GSK) stock price is 1,784p and GlaxoSmithKline’s (GSK) 50-day simple moving average is 1619.26, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is 1,784p and GlaxoSmithKline’s (GSK) 100-day simple moving average is 1508.66, creating a Buy signal.
GlaxoSmithKline’s (GSK) stock price is 1,784p and GlaxoSmithKline’s (GSK) 200-day simple moving average is 1454.66, creating a Buy signal.

GlaxoSmithKline (GSK) Technical Indicators

Nov 18, 2025, 07:48 AM
Name
Value
Implied Action
RSI (14)
68.99
Neutral
STOCH (9,6)
60.41
Neutral
STOCHRSI (14)
83.25
Sell
MACD (12,26)
54.48
Sell
ADX (14)
27.45
Neutral
Williams %R
-18.37
Sell
CCI (14)
63.83
Neutral
ATR (14)
37.59
-
Ultimate Oscillator
41.83
Neutral
ROC
10.43
Buy
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 68.99, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 27.45, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is 63.83, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is 10.43, creating a Buy signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Buy.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 68.99, which suggests GSK is a Neutral.
      What is GSK’s MACD?
      GSK’s MACD is 54.48, which suggests GSK is a Sell.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 1802.00, which suggests GSK is a Sell.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 1730.05, which suggests GSK is a Buy.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 1619.26, which suggests GSK is a Buy.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 1454.66, which suggests GSK is a Buy.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -18.37, which suggests GSK is a Sell.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is 63.83, which suggests GSK is a Neutral.
                    What is the share price of GlaxoSmithKline?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis